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EuropeBackground and purpose: In planning to meet evidence based needs for radiotherapy, guidelines for the
provision of capital and human resources are central if access, quality and safety are not to be compro-
mised. A component of the ESTRO-HERO (Health Economics in Radiation Oncology) project is to docu-
ment the current availability and content of guidelines for radiotherapy in Europe.
Materials and methods: An 84 part questionnaire was distributed to the European countries through their
national scientiﬁc and professional radiotherapy societies with 30 items relating to the availability of
guidelines for equipment and stafﬁng and selected operational issues. Twenty-nine countries provided
full or partial evaluable responses.
Results: The availability of guidelines across Europe is far from uniform. The metrics used for capital and
human resources are variable. There seem to have been no major changes in the availability or speciﬁcs of
guidelines over the ten-year period since the QUARTS study with the exception of the recent expansion of
RTT stafﬁng models. Where comparison is possible it appears that stafﬁng for radiation oncologists,
medical physicists and particularly RTTs tend to exceed guidelines suggesting developments in clinical
radiotherapy are moving faster than guideline updating.
Conclusion: The efﬁcient provision of safe, high quality radiotherapy services would beneﬁt from the
availability of well-structured guidelines for capital and human resources, based on agreed upon metrics,
which could be linked to detailed estimates of need.
 2014 Elsevier Ireland Ltd. Radiotherapy and Oncology 112 (2014) 165–177 This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Many signiﬁcant studies over the last decade have served to fur-
ther conﬁrm the essential role of radiotherapy in the care of cancer
patients [1–3]. Such studies, which have been primarily based on
evidence from the peer reviewed literature and on current best
practice, have not only reinforced the vital role of radiotherapy in
the treatment of cancer but, importantly, provided the community
with quantitative data upon which to base the essential resource
requirements for the delivery of an appropriate radiotherapy
service. These studies are an important part of the context of the
HERO project.
ESTRO’s Health Economics in Radiation Oncology (HERO) pro-
ject has, as its overarching aim, the development of a knowledge
base and model for the health economic evaluation of radiation
treatments in Europe, which can then be used in the design and
justiﬁcation of appropriate services for the populations of Euro-pean countries [4]. The HERO project is currently addressing the
needs for and availability of radiotherapy services in Europe and
will shortly progress to an examination of costs followed by eval-
uations of cost effectiveness.
Limitations on access to appropriate radiotherapy care can take
many forms including insurance and personal wealth in the private
sector, geographic factors and personal biases of referring physi-
cians to mention just a few [5]. However, even assuming such
impediments can be removed, the ultimate limitation on access,
that of the availability of capital and human resources to deliver
safe and high quality radiotherapy, will be encountered in the
majority of countries across the globe.
If the intention is to deliver state of the art radiotherapy, with-
out waiting times and without creating expensive over capacity,
there needs to be guidance at a national or regional level on the
166 European guidelines for radiotherapycapital and human resources required. In this component of the
HERO project, the availability of guidelines for radiotherapy equip-
ment and stafﬁng is examined. Under the QUARTS umbrella, a sim-
ilar survey of European nations was undertaken ten years ago [6]
thus affording the opportunity to identify any signiﬁcant changes
in guideline development over time.
This paper is one of a trilogy, which presents and discusses the
information gleaned from a detailed survey of European countries.
The availability of current capital and human resource data from
the complementary components of the project [7,8] makes it pos-
sible to compare the actual situation with guideline recommenda-
tions in those countries providing the necessary data.Materials and methods
An 84-part web-based questionnaire relating to population and
cancer incidence, radiotherapy courses and resources, guidelines
and reimbursement was developed and distributed to national
scientiﬁc and professional radiotherapy societies, hereinafter
referred to as national societies, in the countries deﬁned by the
European Cancer Observatory (ECO) [9]. The current report
includes a detailed analysis of 30 questions (No. 24, 25, 27, 28,
30–33, 35–41, 43–46 and 61–72) relating to guidelines for radio-
therapy capital and human resources and selected operational
issues. The analysis was conducted in early 2014, and is based on
partial or complete responses from 29 countries. Further details
of the analysis can be found in the Supplementary material.
The 15 equipment speciﬁc items in the questionnaire explored
the availability and content of guidelines not just for linear
accelerators but also for newer technology including multileaf
collimators (MLC), Electronic Portal Imaging Devices (EPID) and
dedicated CT scanners. With the growing demand for radiotherapy
leading to problems of access for many patients, the questionnaire
also sought to identify the criteria used in different countries for
the numbers of machines nationally and per department, e.g., is
the number based on inhabitants, patients or treatments. The issue
of guidelines for satellite centers was also addressed during the
survey.
The ability to deliver safe, high quality radiotherapy will clearly
be compromised by inadequate stafﬁng levels particularly in an
environment where new technology and techniques are being rap-
idly developed and introduced. Details of guidelines for radiation
oncologists, medical physicists, dosimetrists and radiation thera-
pists (RTTs) (including nurses who work directly on treatment
machines) were also sought through the questionnaire.
Four questions addressed speciﬁc operational issues. These
were the percentage of radiation oncologists also delivering che-
motherapy, limitations on working hours as a result of radiation
protection regulations and professional responsibilities for the
key activities of treatment planning and quality assurance.
As with the companion papers [7,8], the relationship between
guideline development and GNI/n was explored using data from
the World Bank Database [10].
Responses were assigned to four categories for the purposes of
analysis and discussion. Where there was no response to a partic-
ular inquiry or the authors of this paper were unable to evaluate
the response, this has been designated n.r. in Tables 1 and 2.
Some responders simply reported that they do not have guide-
lines for the item requested and this is indicated in the tables
(No). Most countries responded to most questions but with
responses of varying degrees of detail. We have separated such
responses into two categories: declared which means that the
country has stated that some basis exists for allocating capital
and human resources and explicit, which is a sub-set of declared,
where the country has provided a metric for identifying orallocating resources. Such metrics include, for example, linear
accelerators per million population and RTTs per linac. Some
countries referred to documents such as the QUARTS study [6]
which include relevant metrics and the guidelines for these coun-
tries were categorized as explicit.
ECO regards the United Kingdom as ‘‘one country’’ although the
survey was distributed to England, Wales, Scotland and Northern
Ireland. If one of those countries responded with a metric to any
question then the response of the UK to that question was inter-
preted as conﬁrming the existence of an explicit criterion based
guideline.
Results
Table 1 summarizes data collected from the questionnaire
regarding radiotherapy equipment and Table 2 presents data from
the stafﬁng survey elements. As the HERO question ‘‘Are there
future plans for radiotherapy needs’’ applies to both capital and
human resources, responses are repeated in both tables. Table 3
gives an insight into the variability of roles and responsibilities of
radiotherapy professionals in various countries by focusing on spe-
ciﬁc radiotherapy tasks (treatment planning and quality assurance)
and on the proportion of radiation oncologists administering che-
motherapy. These three tables encompass 23 of the 30 survey
questions analyzed in this report with the remainder being dis-
cussed in the text. Although 29 countries did respond to the sur-
vey, not all countries responded to every question.
Tables 1 and 2 use shading and fonts to distinguish between
those guidelines assessed as being declared or explicit as deﬁned
above. Where explicit guidelines had been identiﬁed in the previ-
ous QUARTS study [6], this is also indicated in the tables although
the table cells contain the responses to this HERO survey. For
responses to the QUARTS survey, the reader is referred to the ori-
ginal manuscript [6].Cancer plans
21/29 of responding countries have undertaken some level of
planning to accommodate future radiotherapy needs with the
majority approaching this issue at the national level. Three coun-
tries plan on a regional basis. Only 2 responding countries have
developed explicit guidelines for satellites: Belgium requires a
minimum of 500 patients per year and at least 2 machines whereas
in the Netherlands sufﬁcient workload for two machines in combi-
nation with at least 4 linear accelerators at the main site, operating
under the same quality management system, is required in order
to consider establishing a satellite.Equipment
National guidelines for equipment in general exist in 21 of
responding countries. Five countries declared no guidelines and 3
did not respond to this question. Half (15/29) of the general equip-
ment guidelines are stated as being national with an additional 3
being attributed to professional society recommendations, which
are presumably national too, 2 that are based on the (unspeciﬁed)
literature and 1 which is under development. Although 8 countries
either did not respond to this question or declared having no
national general equipment guidelines, 2 of these countries did
specify explicit guidelines when queried about the inventory of
machines at the national level.
Turning to guidelines for treatment machine inventory at the
national level, 25 countries declared guidelines with 11 being
explicit as deﬁned above. The basis for the calculation of the
required number of linear accelerators nationally was exclusively
the population served in 9 jurisdictions and exclusively the
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using multiple criteria in establishing recommended national
equipment inventories and 1 country referred to ‘‘literature’’. 17
responders declared guidelines for the number of machines per
department with 7 being explicit and based on the number of
patients or treatment courses or fractions or some combination.
12 respondents declared explicit criteria for the minimum number
of machines per department. This minimum number was typically
2 but ranged from 1 to 4. As cobalt units continue to be phased out
(Grau et al. [7] report that less than 5% of all MV units in Europe are
Cobalt machines) it is not surprising that there are fewer recom-
mendations speciﬁcally addressing this treatment modality
(Supplementary material). Eleven countries group requirements
for megavoltage units, i.e., linear accelerators and cobalt units,
together.
Explicit numerical criteria for simulation facilities were
declared in 17 of the surveyed countries. The guideline is typically
stated in terms of either numbers per center, e.g., 1, per center, or
per linac, ranging from 1 simulator to 1 linear accelerator or 1 sim-
ulator to 4 linear accelerators.
Relatively few responders to this questionnaire have explicit
recommendations on newer technology such as multileaf collima-
tors (3), electronic portal imagers (5) and dedicated CT-scanners
(9). There was some form of recommendation for ancillary quality
assurance equipment in only 10 responses.Stafﬁng
Table 2 summarizes selected responses to those questions
addressing guidelines on clinical stafﬁng for radiation treatment
facilities. 24 of the responding 29 countries do have recommenda-
tions for stafﬁng levels. These recommendations are mainly at the
national level and may be based on recommendations from IAEA
[11], EFOMP [12], EORTC [13] or national professional societies.
As stafﬁng levels are likely to be inﬂuenced by working hours,
HERO sought information on this aspect of employment contracts.
Thirteen countries provided details of working hour limitations for
radiotherapy professionals although several respondents pointed
out that there were differences between the public and private sec-
tors. In two instances limiting working hours would be as a result
of the level of radiation exposure.
Guidelines for the number of radiation oncologists were present
in 27/29 of responding countries, of which 16 were explicit with
recommendations ranging from 130 to 300 patients per year per
oncologist. Sufﬁcient stafﬁng to ensure that a radiation oncologist
was always present when patients were being treated was
mentioned in two responses. As demonstrated in Table 3, in about
three quarters of the countries (23) radiation oncologists are
administering chemotherapy as well as radiotherapy.
Twenty-ﬁve of 29 responding countries reported guidelines for
the number of medical physicists. Of these, 19 were explicit: up to
2.75 physicists per machine, or from 400 to 750 patients per phys-
icist. 11 countries reported stafﬁng guidelines for dosimetrists, of
which 3 were explicit, and 27 for the number of RTTs, of which
20 were explicit. In the majority, the numbers of RTTs needed were
expressed per linac with a range of 2–6, while, in only 4 countries,
workload (annual patients or treatments delivered per RTT)
deﬁned their numbers.
Twenty-two countries reported the involvement of physicists,
with or without others, in treatment planning while physicists,
with or without others, continue to perform most (28/29) of the
quality assurance procedures with physics assistants playing a role
in some countries (Table 3).
In the companion papers [7,8] strong correlations were found
between the inventories of capital equipment and stafﬁng and
GNI/n. No such relationship exists for the availability of guidelines.
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Table 2 (continued)
n.r. = not reported, not available or no evaluable response was given to the question.
Light shaded: guideline was declared to the HERO survey.
Dark shaded: an explicit guideline was declared to the HERO survey. See text for deﬁnition of explicit.
Italics: an explicit guideline had been previously been declared to the QUARTS survey (6).
Npts: new patients, L: linear accelerator, MV: mega voltage machine.
The authors have attempted to reproduce as faithfully as possible, within space limitations, the national societies’ responses.
⁄Countries with one radiotherapy center.
1Additional stafﬁng for special procedures (STX, Whole Body Irradiation, IMRT, IORT): one additional radiation oncologist and RTT per every 100 cases/year; one additio al medical physicist per every 200 cases/year.
2Národní Radiologické Standardy – Radiacˇní Onkologie [National Radiological standards-Radiation Oncology], 2012.
3Livre Blanc de la Radiotherapie 2013 [White book of Radiotherapy].
4Strahlenschutzverordnung [Radiation Protection Guidance].
5Institution can have different working hours [ in terms of Schichtbetried referring to 8 h daily, i.e., 1½ Schichtbetried correspond to 12 h/day]. For RO and MP, if the orga zational structure is of 2 Schichtbetried:+1/2 device; for
RTT: 2 RTT/device.
6For details on the complex rules, see guideline.
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Table 3
Tasks performed by different radiotherapy professionals.
Country % ROs administering chemotherapy Most treatment planning performed by Most QA procedures performed by
Albania 0% Medical physicists Medical physicists, technicians/engineers
Austria 25–75% Technologists, radiographers Medical physicists
Belarus 25–75% Medical physicists, but sometimes it’s
performed trained radiation oncologists
Medical physicists, technicians/engineers
Belgium <25% Dosimetrists Medical physicists
Bulgaria 25–75% Medical physicists Medical physicists, technicians/engineers
Czech Republic >75% Medical physicists Medical physicists
Denmark >75% Medical physicists Medical physicists
Estonia >75% Medical physicists Medical physicists
Finland >75% Medical physicists Medical physicists
France 25–75% Medical physicists, dosimetrists,
technologists, radiographers
Medical physicists, technicians/engineers
Germany 25–75% Medical physicists Medical physicists, RTT
Hungary 25–75% Medical physicists Medical physicists
Iceland >75% Technologists, radiographers Medical physicists
Ireland 0% Technologists, radiographers Medical physicists
Italy >75% Medical physicists Medical physicists
Lithuania 0% Medical physicists, radiation oncologists Medical physicists
Luxembourg >75% Medical physicists, dosimetrist Medical physicists, technicians/engineers
Malta >75% Medical physicists Medical physicists
Montenegro 0% Medical physicists Medical physicists
The Netherlands 0% Technologists, radiographers Physics assistants
Norway >75% Technologists, radiographers Medical physicists
Poland <25% Medical physicists Medical physicists
Portugal 0% Dosimetrists Medical physicists, technologist/radiographers
Romania 25–75% Medical physicists Medical physicists
Slovak Republic 25–75% Medical physicists Medical physicists
Slovenia >75% Medical physicists, dosimetrists Medical physicist with the help of technicians/engineers
Spain <25% Medical physicists, dosimetrist Medical physicists, technicians
Switzerland <25% Medical physicists, dosimetrists,
technologists, radiographers
Medical physicists, technicians/engineers, technologist/
radiographers, dosimetrist
United Kingdom >75% Medical physicists, dosimetrists,
technologists, RTT
Medical physicists, technicians/engineers
England >75%, About 50% time of radiation
oncologist devotes their time to
supervising chemotherapy
Dosimetrists, technologists, radiographers Medical physicists, technicians/engineers
Scotland >75% Medical physicists, dosimetrists, RTTs, it
varies between departments depending
on skill mix
Medical physicists, technicians/engineers
Wales >75% Medical physicist, technologists Medical physicists, technicians
Northern Ireland >75% Medical physicists, dosimetrists Daily machine checks are carried out by radiographers,
medical physicists, technicians/engineers, technologists/
radiographers
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lines as the wealthier (Supplementary material).
Complete results of the HERO survey and additional commen-
tary are available in the Supplementary material.Discussion
While some of the information sought in the current survey was
similar to that incorporated in the previous QUARTS study [6], the
current study was more extensive but with a slightly lower overall
response rate. Of the 40 ECO countries included, 29 responded in
total or in part to this guidelines component of the HERO survey.
QUARTS elicited responses from 41 countries [6].
Turning ﬁrst to the equipment component, a higher number of
countries declared having guidelines for the total number of linacs
required nationally than was the case ten years ago (25 vs. 17).
However, only 11 of the 25 guidelines identiﬁed during the HERO
survey were categorized as explicit whereas all 17 of those
reported by QUARTS [6] had criteria associated with them. It can
also be observed that there are differences between the group of
countries which reported explicit guidelines to the QUARTS study
and to the present HERO survey (Tables 1 and 2). Where such
national guidelines exist, these are currently based, entirely or par-
tially, on the population in 14/25 of responses compared with 10/17 for QUARTS. 13/25 guidelines at the national level are based on
the number of patients/treatment courses compared with 7/17 for
QUARTS, although, as noted above, there are many cases where
more than one criterion is used. At the department level, similarly,
14 countries’ linear accelerator guidelines depend on the number
of patients, treatments and/or fractions with 7 of these being
explicit. Although 13 countries have established satellite centers
[7], only 2 responding countries have developed explicit criterion
based guidelines.
Fig. 1 compares QUARTS and HERO guidelines with actual meg-
avoltage unit workload as reported by Grau et al. [7]. Although the
data are incomplete, with only 9/29 comparable data sets, it
appears that, for these countries, explicit guidelines for courses
per machine have not changed greatly over ten years. It was noted
during the analysis that three countries, Austria, Czech Republic
and Poland, deﬁned megavoltage unit workload in terms new
patients for the QUARTS survey but patients, i.e., not specifying
new patients, for this HERO survey. For consistency with the
companion publications [7,8], where new patients are speciﬁed
in a questionnaire response for either QUARTS or HERO a multi-
plier of 1.25 is applied to yield total patients (courses) treated.
One country, the Netherlands is notable in reporting a lower
number of courses per machine than their national guideline
recommends. This could reﬂect clinical exigencies overtaking
Fig. 1. QUARTS guidelines, HERO guidelines and actual (HERO) megavoltage unit workload. Notes: Dotted lines are the ranges when provided by countries. Only countries
having data from at least two of the three data sources are shown. HERO and QUARTS guideline data have been adjusted for a 25% re-treatment rate whenever the guideline
stated explicitly new patients.
174 European guidelines for radiotherapyguideline development as more complex and time-consuming
treatments are introduced.
Guidelines for the lifetimes of treatment machines, at 8–
15 years with a most frequent value of 10 years, appear not to have
changed over the last decade. One respondent only stated a recom-
mended lifetime for simulators and that was 10 years (Supplemen-
tary material). Of course, the lifetime of a machine is determined at
least partly by technological obsolescence in a rapidly changing
environment, which makes the development of such lifetime
guidelines challenging. However, in-the-ﬁeld upgrades, such as to
Volumetric Modulated Arc Therapy, are an increasingly popular
and practical means of maintaining state of the art capability.
Rapid technological changes may also explain the paucity of
explicit recommendations for newer devices such as multileaf col-
limators, electronic portal imagers and CT simulators. While only a
third of responding countries had criterion based guidelines for CT
simulators, 26 countries participating in this study have such
devices [7]. It is noted that two countries regard amultileaf collima-
tor as a standard feature of a linac purchase (Table 1) constituting
an implied guideline. Although the number of formal guidelines
for multileaf collimators is small, over half the linacs installed are
IMRT capable, implyingwidespread adoption of this newer technol-
ogy [7]. Surprisingly there seem to be fewer recommendations on
the number of treatment planning workstations than there were
10 years ago (21% vs. 40%) although this may be a reﬂection of
the introduction of networked conﬁgurations as opposed to
stand-alone systems.
Twenty-seven of 29 respondents report having guidelines for
the number of radiation oncologists although only 16 of these
are explicit. This compares with 17 of the 41 countries responding
to the QUARTS survey [6]. The workload for radiation oncologists is
presently recommended to be between 130 and 300 patients per
year which is slightly lower than that found in the QUARTS study
where the range was 150–350 patients annually [6]. This reduction
in workload is reﬂected in the recent data on personnel resources
gathered through the HERO project [8]. This may in part echo the
increase in treatment complexity and related time requirements
observed in the past decade. Interestingly, however, there is also
a suggestion that the number of radiation oncologists delivering
chemotherapy has increased somewhat over the last ten years. In
the present study 38% (11/29) of countries reported that >75% of
radiation oncologists deliver chemotherapy whereas it was 19.5%
in the QUARTS study. Correspondingly, <25% of radiation oncolo-gists currently deliver chemotherapy in 14% (4/29) of countries
whereas the comparable number was 39% ten years ago [6]. This
change may be a reﬂection of the increased uptake of concurrent
chemo-radiation protocols [7].
Guidelines for the number of physicists are now present in 25/
29 of countries, of which 19 are explicit, compared to 18/41 (expli-
cit) in QUARTS. However, any change from the recommended staff-
ing levels reported in the QUARTS study is lost in the variability of
the responses. Stafﬁng guidelines for dosimetrists were not
reported in the QUARTS study. Currently, there are 10 guidelines
for dosimetrist stafﬁng of which 2 are explicit. As noted in the com-
panion paper [8], and is apparent from Table 3, there is overlap in
the functions of medical physicists, dosimetrists and RTTs particu-
larly in the area of treatment planning. This may be part of the rea-
son for the relatively small number of guidelines for dosimetrists.
This survey has identiﬁed 27 guidelines for RTTs, of which 19 are
explicit, compared with 19 in the QUARTS study [6]. As was noted
in the HERO stafﬁng paper [8], guidelines typically link the number
of RTTs or nurses to machines which, in turn, are frequently linked
to the population base being served. It would be more appropriate
to use fractions, perhaps including complexity, as the basis for RTT
stafﬁng models as fractions are a more accurate reﬂection of actual
workload.
It is possible to compare recommendations made in stafﬁng
guidelines reported during this survey with those reported 10 years
ago as part of the QUARTS study [6] and with the actual situation
[8]. Fig. 2 shows such comparisons for radiation oncologists and
medical physicists. Fig. 3 shows comparisons between guidelines
reported to this study and actual stafﬁng levels [8] for RTTs per
machine. Such data were not collected during the QUARTS study
[6]. Where both HERO and QUARTS explicit guidelines for radiation
oncologists and physicists do exist, it is apparent that they have not
changed greatly over ten years. However, for both radiation oncol-
ogists and medical physicists the actual number of courses per pro-
fessional is lower than guidelines in three quarters of responding
countries. This may be another example of increasing clinical
complexity overtaking guideline development. Similarly, in all ﬁve
evaluable reports, RTT stafﬁng exceeded recommendations, some-
times by a considerable margin (Fig. 3).
In addition to using QUARTS [6] as a basis for guidelines, many
countries refer to recommendations from other organisations such
as IAEA [11], EFOMP [12], EORTC [13] and IPEM [14]. These recom-
mendations seem to have been accepted as some kind of ‘gold stan-
Fig. 2. QUARTS guidelines, HERO guidelines and actual (HERO) staff workload. Notes: Only countries having data from at least two of the three data sources are shown. Dotted
lines are the ranges when provided by countries.
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tend be somewhat similar, based, as they are, on prevailing practice
about a decade ago. But none of these has ever looked at real needs
as determined by actual cancer statistics as a basis for doing so
[1–3] was not available at the time of development. Moreover,
there does not seem to exist a tradition of periodic updates. Those
changes that do happen can be provoked by ad-hoc incentives such
as radiotherapy accidents or enforced safety regulations and not as
part of a regular review. For example, in Poland much stricter reg-
ulations on staff, equipment and maintenance were passed after
the patients’ overdosage in Bialystok in 2001 [15], while in France
a strict regulation on reporting and public informationwas initiated
after the events in Epinal in 2004–5 [16]. It is apparent from a com-
parison of the results presented here with those in the companion
papers [7,8] that the process of guideline updating is much slower
than changes in practice.With sophisticated models such as those developed by Delaney
et al. [1,3] and/or best practice studies of the type conducted by the
group at Queen’s University [2] it is possible to estimate demand,
within some level of accuracy, based on the cancer proﬁles of the
country or region [9]. The role of guidelines of the type surveyed
here is to translate demand into operational parameters such as
numbers of machines, numbers and types of staff and the other
characteristics of a radiotherapy treatment facility. With advancing
technology, such as Image Guided Radiation Therapy, and changing
practice, for example Stereotactic Ablative Body Radiotherapy, it
has to be acknowledged that guidelines will need to be under con-
stant review. However, without guidelines, or non-adherence to
guidelines, the introduction of new facilities or upgrading of cur-
rent facilities can become haphazard with instabilities compromis-
ing safety and quality, and possibly waste through unnecessary
duplication and inefﬁcient use of limited resources [8].
Fig. 3. Number of RTTs and radiotherapy nurses per mega voltage unit. Notes: Only
countries having data from at least two of the three data sources are shown. Dotted
lines are the ranges when provided by countries.
176 European guidelines for radiotherapyAlthough over half the countries responding to this question-
naire do have plans for future radiotherapy equipment and staff-
ing, the recommendations analyzed here suffer from several
limitations that render them insufﬁcient to forecast the evolution
in human and capital resource requirements for modern radiother-
apy. Key elements, such as acknowledging the role of volumetric
imaging, seem to be lacking. From Table 1 it can be inferred that
the level of detail of existing capital resource guidelines decreases
with the newness of the technology, for example multileaf collima-
tors and portal imagers. Moreover, even where a substantial
number of guidelines does exist, such as for linear accelerators, dif-
ferent denominators are used: inhabitants, patients, and fractions.
Are patients new patients or is it courses that are meant? The same
variability in denominators is observed for stafﬁng guidelines
(Table 2). For example, for RTTs sometimes it is the number of
patients treated but mostly it is therapists per linac. The same
holds for medical physicists. Resource recommendations, whether
for capital or human resources, should be stated as input divided
by output (or vice versa). RTTs (and other staff) and linacs are both
inputs to the radiotherapy process so specifying stafﬁng recom-
mendations as RTTs per linac does not make sense without also
specifying fractions per hour or some such metric. Not asked for
in this study, but clearly of relevance, are the operating hours of
linear accelerators and other equipment: double the number of
hours and half the amount of equipment, although lifetime might
be reduced [17]. Of course operating hours can also confound staff-
ing models which are based on RTTs per linac, for example, instead
of some valid measure of output such as fractions treated. An IAEA
initiative, currently underway, is designed to accommodate this
necessary level of complexity by including working hours in the
estimation of personnel resources needed [18].
The current recommendations for equipment, staff and staff
mix show signiﬁcant variability. With downward pressures on
budgets in most jurisdictions [19], it behooves the radiation treat-
ment community to get a better handle on the capital and human
resources required to deliver safe, high quality radiotherapy in themodern era. Looking to the future, stafﬁng algorithms could, for
example, provide the basis for examining the impact of substitut-
ing generalists (assistants) for specialists as economic and demo-
graphic pressures force us to rethink our operational models.
There is no evidence from the current survey that such a shift
has started yet.
There are, of course, limitations to the study presented here.
The most signiﬁcant has resulted from the challenge of interpret-
ing the responses submitted by the national societies. Some were
brief and some were much more detailed. Given publication space
restrictions, the authors were obliged to distill the responses down
to the salient points. To minimize the risk of misinterpreting
responses, the national societies were asked for clariﬁcations as
the analysis proceeded and have been given the opportunity to
review their data as presented in this paper. A ﬁnal ambiguity is
associated with the question as to whether or not the guidelines
reported by the national societies have any legal status or are rec-
ommendations for best practice.
To assist the national societies within ESTRO and to promote
high standards of quality and accessibility for all European cancer
patients, in an environment of shrinking budgets, a strong argu-
ment could be made for the continuing development of templates
to guide the planning of radiotherapy facilities in the European
nations. To be useful in the medium to long term, such templates
would have to accommodate the dynamic technological environ-
ment in which radiotherapy is delivered. The IAEA initiative to
develop a stafﬁng estimator based on performed activities and time
estimates would be an appropriate starting point [18]. The knowl-
edge base created through other components of the HERO project
complement the development of such templates by facilitating
the prediction of evidence based demand for radiotherapy services.Conclusions
There have been no major changes in the availability or speciﬁc-
ity of equipment and stafﬁng guidelines in the European countries
in the last ten years with the exception of those for RTT stafﬁng. In
the nations which could be evaluated here, actual stafﬁng for radi-
ation oncologists, physicists and particularly RTTs mostly exceed
those in current guidelines. While it is acknowledged that the
development of human and capital resource guidelines in a rapidly
changing technological environment is challenging, the provision
of sustainable, safe, high quality radiotherapy services to the pop-
ulation of Europe would beneﬁt from progress in this regard. A
consensus developed template, using consistent terminology and
metrics, for the planning of radiotherapy resources could facilitate
the availability of this pillar of cancer management.Conﬂict of interest statement
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